Home›People›Derek Yoon
DY

Derek Yoon

Director at EvolveImmune Therapeutics Holding Company.

Director
Updated Nov 15, 2026·Latest SEC filing Nov 1, 2024·Suggest an edit

About Derek Yoon

Form D filings for EvolveImmune Therapeutics Holding Company from 2023 to 2024 list Derek Yoon as director.

Derek Yoon first appears on SEC filings in 2023.

Experience

This experience comes from SEC filings. The years are when the filings name Derek Yoon in the role, so the role may have started earlier or lasted longer.

EvolveImmune Therapeutics Holding Company, LLC
Director
2023 – 2024 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.

Key Colleagues at Startups

The people Derek Yoon works with at each company, as listed on that company's latest Form D.

IT
Ian Taylor
Director
SB
Stephen Bloch
Co-founder and Chief Executive Officer, director
DP

Sources

  1. SECEvolveImmune Therapeutics Holding Company, LLC Form D, filed Nov 1, 2024